NEW YORK (GenomeWeb News) – UK Prime Minster David Cameron today unveiled a £311 million ($523 million) investment package that includes a partnership between Genomics England and Illumina and will fund its national genome sequencing initiative, the 100,000 Genomes Project.

The UK created Genomics England as a company wholly owned by the Department of Health to oversee its effort to sequence and analyze the genomes of 100,000 people, a project that aims to advance the larger goal of integrating genomic medicine into the National Health Service.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.